Menu
GWAS Study

Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.

Chen JA, Chen Z, Won H et al.

30089514 PubMed ID
GWAS Study Type
12308 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CJ
Chen JA
CZ
Chen Z
WH
Won H
HA
Huang AY
LJ
Lowe JK
WK
Wojta K
YJ
Yokoyama JS
BG
Bensimon G
LP
Leigh PN
PC
Payan C
SA
Shatunov A
JA
Jones AR
LC
Lewis CM
DP
Deloukas P
AP
Amouyel P
TC
Tzourio C
DJ
Dartigues JF
LA
Ludolph A
BA
Boxer AL
BJ
Bronstein JM
AA
Al-Chalabi A
GD
Geschwind DH
CG
Coppola G
Chapter II

Abstract

Summary of the research findings

Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease for which the genetic contribution is incompletely understood.

1,646 European ancestry cases, 10,662 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

12308
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S., France, Germany, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.